Delta-Fly Pharma, Inc. announced a private placement to issue 430,300 shares at an issue price of ¥1,162 per share for the gross proceeds of ¥500,008,600 and 10,800 units 7th stock acquisition rights at an issue price of ¥344 for the gross proceeds of ¥3,715,200; aggregate gross proceeds of ¥503,723,800 on October 20, 2023. The transaction will include participation from new investor Nippon Chemiphar Co., Ltd. The transaction has been approved by the shareholders of the company and is expected to close on November 10, 2023.